SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-018477
Filing Date
2023-02-10
Accepted
2023-02-10 16:00:19
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm235947d17_sc13g.htm SC 13G 73741
  Complete submission text file 0001104659-23-018477.txt   75516
Mailing Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036
Business Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Subject) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-88883 | Film No.: 23611629
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

IRS No.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G